| Region 8q24 is a susceptibility locus for nonsyndromic oral clefting in Brazil LA Brito, LMR Paranaiba, CFS Bassi, C Masotti, C Malcher, D Schlesinger, ... Birth Defects Research Part A: Clinical and Molecular Teratology 94 (6), 464-468, 2012 | 50 | 2012 |
| Human stem cell cultures from cleft lip/palate patients show enrichment of transcripts involved in extracellular matrix modeling by comparison to controls DF Bueno, DY Sunaga, GS Kobayashi, M Aguena, CE Raposo-Amaral, ... Stem cell reviews and reports 7 (2), 446-457, 2011 | 46 | 2011 |
| IRF6 is a risk factor for nonsyndromic cleft lip in the Brazilian population LA Brito, CFS Bassi, C Masotti, C Malcher, KM Rocha, D Schlesinger, ... American Journal of Medical Genetics Part A 158 (9), 2170-2175, 2012 | 44 | 2012 |
| Intratumoral genetic heterogeneity in rectal cancer: are single biopsies representative of the entirety of the tumor? F Bettoni, C Masotti, A Habr-Gama, BR Correa, J Gama-Rodrigues, ... Annals of surgery 265 (1), e4-e6, 2017 | 42 | 2017 |
| TCOF1 mutation database: Novel mutation in the alternatively spliced exon 6A and update in mutation nomenclature A Splendore, RD Fanganiello, C Masotti, LSC Morganti, ... Human mutation 25 (5), 429-434, 2005 | 42 | 2005 |
| Re-transplantation, higher creatinine levels in hepatitis C virus patients, and donor age are predictors of mortality in long-term analysis of late acute rejection in liver … LS Nacif, RS Pinheiro, RA de Arruda Pécora, RY Tanigawa, ... Medical Science Monitor 22, 9-16, 2017 | 35* | 2017 |
| A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA–protein interaction C Masotti, LM Armelin-Correa, A Splendore, CJ Lin, A Barbosa, ... Gene 359, 44-52, 2005 | 34 | 2005 |
| Auriculo-condylar syndrome: mapping of a first locus and evidence for genetic heterogeneity C Masotti, KG Oliveira, F Poerner, A Splendore, J Souza, ... European journal of human genetics 16 (2), 145-152, 2008 | 32 | 2008 |
| Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines F de Carvalho, ET Costa, AA Camargo, JC Gregorio, C Masotti, ... PloS one 6 (11), e27707, 2011 | 24 | 2011 |
| Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines F de Carvalho, ET Costa, AA Camargo, JC Gregorio, C Masotti, ... PloS one 6 (11), e27707, 2011 | 24 | 2011 |
| Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients C Masotti, CC Ornelas, A Splendore-Gordonos, R Moura, TM Félix, ... BMC Medical Genetics 10 (1), 1-7, 2009 | 21 | 2009 |
| Understanding human DNA variants affecting pre-mRNA splicing in the NGS era LG Dufner-Almeida, RT do Carmo, C Masotti, LA Haddad Advances in genetics 103, 39-90, 2019 | 9 | 2019 |
| Analysis of allelic differential expression in the human genome using allele-specific serial analysis of gene expression tags DO Vidal, JES de Souza, LC Pires, C Masotti, ACM Salim, MCF Costa, ... Genome 54 (2), 120-127, 2011 | 9 | 2011 |
| The effects of neoadjuvant chemoradiation in locally advanced rectal cancer—the impact in intratumoral heterogeneity F Bettoni, C Masotti, BR Corrêa, E Donnard, FF Dos Santos, ... Frontiers in oncology 9, 974, 2019 | 6 | 2019 |
| MRPL53, a New Candidate Gene for Orofacial Clefting, Identified Using an eQTL Approach C Masotti, LA Brito, AC Nica, KU Ludwig, K Nunes, CP Savastano, ... Journal of dental research 97 (1), 33-40, 2018 | 5 | 2018 |
| Does germ-line deletion of the PIP gene constitute a widespread risk for cancer? AG Silva, ACV Krepischi, GT Torrezan, LP Capelli, DM Carraro, ... European Journal of Human Genetics 22 (3), 307-309, 2014 | 4 | 2014 |
| HLApers: HLA Typing and Quantification of Expression with Personalized Index VRC Aguiar, C Masotti, AA Camargo, D Meyer Bioinformatics for Cancer Immunotherapy, 101-112, 2020 | 1 | 2020 |
| Revealing the BRD4-NOTCH3 fusion: A novel hill in the cancer landscape F de Almeida Costa, MT Amano, PF Asprino, DC Pavlick, C Masotti, ... Lung Cancer 154, 146-150, 2021 | | 2021 |
| Detection of ESR1 mutations in plasma cell-free DNA from metastatic ER-positive breast cancer patients resistant to hormone therapy C Masotti, FH Knebel, RDM Linck, J Lima, AK Shimada, JV Alessi, ... CLINICAL CANCER RESEARCH 26 (11), 43-44, 2020 | | 2020 |
| Abstract A19: Detection of ESR1 mutations in plasma cell-free DNA from metastatic ER-positive breast cancer patients resistant to hormone therapy C Masotti, FH Knebel, RDM Linck, J Lima, AK Shimada, JV Alessi, ... Clinical Cancer Research 26 (11 Supplement), A19-A19, 2020 | | 2020 |
